Clinical Trial Update: Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients [Phase 3]

View source ↗

Summary

A multicenter Phase 3 clinical trial evaluating lumateperone for irritability in pediatric patients with autism spectrum disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Lumateperone (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Irritability Associated With Autism Spectrum Disorder | Phase 3 | Status: RECRUITING